Biolase (BIOL) Reports In-Line Q1 EPS

Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $10 million versus the consensus estimate of $10.96 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Parsons Corporation (PSN) Tops Q2 EPS by 10c; Offers Guidance
• Amphenol (APH) Tops Q2 EPS by 19c ; Offers Guidance
• Diebold Nixdorf (DBD) Misses Q2 EPS by 13c ; Offers Guidance